Christian Schulz

Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus report

Peter Malfertheiner, Françis Mégraud, Theodore Rokkas et al. · Gut · 2022 · 1.4K citations · Full text

Medicine, Infectious Diseases, Microbiology +16

The active bacterial assemblages of the upper GI tract in individuals with and without <i>Helicobacter</i> infection

Christian Schulz, Kerstin Schütte, Nadine Koch et al. · Gut · 2016 · 216 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function

Fabian Frost, Tim Kacprowski, Malte Rühlemann et al. · Gut · 2020 · 187 citations · Full text

Life Sciences, Microbiology, Metabolic Stability +13

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Tanja Trarbach, Markus Moehler, Volker Heinemann et al. · British Journal of Cancer · 2010 · 180 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15